Page last updated: 2024-09-03
cgp 42112a and leptin
cgp 42112a has been researched along with leptin in 1 studies
Compound Research Comparison
| Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
|---|---|---|---|---|---|
| 233 | 0 | 35 | 25,940 | 1,628 | 11,468 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adachi, M; Fukui, T; Hirano, T; Kageyama, H; Okada, K; Ran, J; Saito, K | 1 |
Other Studies
1 other study(ies) available for cgp 42112a and leptin
| Article | Year |
|---|---|
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucose Tolerance Test; Hypertension; Imidazoles; Injections, Subcutaneous; Insulin; Insulin Resistance; Leptin; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptors, Adiponectin; Receptors, Cell Surface; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |